Select Medical Holdings Corporation (NYSE:SEM) Receives $17.80 Consensus PT from Brokerages

Shares of Select Medical Holdings Corporation (NYSE:SEM) have received an average rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $17.80.

Several brokerages recently weighed in on SEM. Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, October 8th. Bank of America reduced their target price on shares of Select Medical from $18.00 to $15.00 and set a “buy” rating on the stock in a report on Wednesday, September 10th. Royal Bank Of Canada increased their price target on shares of Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a report on Wednesday, October 8th. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Mizuho set a $17.00 price objective on Select Medical in a research report on Monday, November 3rd.

Select Medical Trading Up 0.1%

Shares of SEM stock opened at $14.84 on Monday. The stock’s 50-day moving average price is $14.29 and its 200-day moving average price is $13.87. Select Medical has a 12-month low of $11.65 and a 12-month high of $20.83. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of 17.26, a price-to-earnings-growth ratio of 0.56 and a beta of 1.28. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.05. The business had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Select Medical had a return on equity of 7.41% and a net margin of 2.05%.The firm’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.43 EPS. Select Medical has set its FY 2025 guidance at 1.140-1.240 EPS. Equities research analysts predict that Select Medical will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Investors of record on Wednesday, November 12th were given a $0.0625 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.25 dividend on an annualized basis and a yield of 1.7%. Select Medical’s dividend payout ratio (DPR) is currently 29.07%.

Institutional Investors Weigh In On Select Medical

Several institutional investors have recently made changes to their positions in SEM. Russell Investments Group Ltd. boosted its stake in shares of Select Medical by 143.8% during the 1st quarter. Russell Investments Group Ltd. now owns 111,796 shares of the health services provider’s stock worth $1,867,000 after purchasing an additional 65,946 shares during the period. American Century Companies Inc. boosted its position in shares of Select Medical by 32.0% during the first quarter. American Century Companies Inc. now owns 181,102 shares of the health services provider’s stock valued at $3,024,000 after buying an additional 43,933 shares during the period. Quantbot Technologies LP purchased a new position in shares of Select Medical during the first quarter valued at approximately $489,000. Hsbc Holdings PLC raised its holdings in shares of Select Medical by 1.9% in the first quarter. Hsbc Holdings PLC now owns 94,084 shares of the health services provider’s stock worth $1,578,000 after buying an additional 1,779 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Select Medical during the 1st quarter worth approximately $60,000. Institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.